1, These are all reasons why GAVI chose the pneumococcal vaccine for its first Advance Market Commitment project.

2, Like the flu shot, the pneumococcal vaccine, which protects against pneumonia, meningitis and bacteremia (a blood infection), is recommended for older adults, and those with established heart disease.

3, As pneumococcal vaccine became the most key of a type of medicine to prevent from the pneumococcal disease, its usage got more and more attention.

4, The pneumococcal vaccine will therefore be particularly important to save lives in the most disadvantaged populations.

5, "If fully rolled out in GAVI-eligible countries, the pneumococcal vaccine could save the lives of more than 440, 000 children by 2015, " said Dr. Julian Lob-Levyt,(http:///pneumococcal vaccine.html) CEO of the GAVI Alliance.

6, To provide scientific reference for the use of pneumococcal vaccine, this article describes the pneumococcal vaccine development and schedules, immunization effect and application.

7, But pneumococcal vaccine might be a different situation and one in which there might be no urgency to vaccinate.

8, What we did for the pneumococcal vaccine was we said we will pay one point five billion dollars if you develop the right vaccines, and the right volumes that we need and at the right price.

9, Before having a splenectomy, anyone with HS should have the pneumococcal vaccine.

10, Meanwhile , our country has made progress on this research. Better use pneumococcal vaccine to prevent from a series of disease become the key work from now on.

11, He said one aim would be to cut the cost of the pneumococcal vaccine from US$100 per dose to US$5 per dose.

12, And then 18 more countries will receive funding to introduce the pneumococcal vaccine.

13, This result could be considered somewhat surprising, according to Siriwardena, as one recent study did suggest a potential protective effect of the pneumococcal vaccine.

14, In 2000, only the USA had initiated routine use of pneumococcal vaccine.

15, Pneumococcal surface protein A (PspA) and pneumolysin have been identified as candidate pneumococcal vaccine factors, although the focus of their immune protection varies.